Atlanta, GA
Chelation Therapy clinics in Atlanta
Chelation therapy in Atlanta is offered by a small set of integrative and naturopathic clinics, typically for documented heavy metal toxicity confirmed by provocation or baseline testing. Common agents include calcium disodium EDTA, DMPS, DMSA, and deferoxamine, each with specific binding profiles for lead, mercury, arsenic, or iron.
Most Atlanta chelation providers are MDs or DOs with ACAM training, and in some states naturopathic doctors within their licensed scope. Protocols vary from 10-session courses for basic detoxification to longer 30-session cardiovascular protocols modeled on the TACT trial. Pricing is cash-pay in almost every case, and no insurance covers off-label chelation.
With verified chelation therapy clinics on Regenerated.com in Atlanta, Georgia, patients can compare provider credentials, testing protocols, and agent selection. Regenerated.com does not recommend chelation for cardiovascular disease or autism. The FDA has only approved specific agents for specific heavy metal poisoning diagnoses. Chelation outside that narrow indication is off-label, and in the wrong hands it has caused deaths.
Pravida Health
- PRP Therapy
- IV Therapy
- Laser Therapy (LLLT)
- Hyperbaric Oxygen Therapy (HBOT)
- Arthritis Treatment
Hol +
- Vitamin IV Therapy
- IV Therapy
- Arthritis Treatment
- Chelation Therapy
- Lyme Disease Treatment
Institute for Health Hope & Success
- Stem Cell Therapy
- NAD IV Therapy
- PRP Therapy
- Biofeedback Therapy
- Shockwave Therapy
Atlanta Ozone Therapy Clinic
- Ozone Therapy
- IV Therapy
- Hyperbaric Oxygen Therapy (HBOT)
- Oxygen Therapy
- Arthritis Treatment
Regulatory context
A note on Georgia's chelation therapy rules.
The FDA has approved a narrow set of chelating agents for specific heavy metal toxicities. Calcium disodium edetate (CaNa2EDTA, Versenate) is approved for symptomatic lead poisoning, succimer (Chemet, DMSA) for pediatric lead poisoning at blood lead levels above 45 mcg/dL, deferoxamine (Desferal) and deferasirox (Exjade) for chronic iron overload, and dimercaprol (BAL) for arsenic, gold, and acute lead poisoning. Use of EDTA chelation for cardiovascular disease was studied in the NIH-funded TACT trial (2013) with controversial findings and remains not FDA-approved for that indication. Chelation for autism spectrum disorder is not evidence-based and has been linked to pediatric deaths. The FDA issued a 2010 sweep of warning letters to compounders marketing OTC chelation products with unapproved disease claims.
-
Georgia Medical Practice Act, O.C.G.A. Title 43, Chapter 34
Governs MD and DO practice in Georgia including chelation administration.
The Georgia Composite Medical Board has investigated practitioners for chelation marketing claims related to autism, cardiovascular disease, and chronic illness. Georgia does not license NDs, restricting chelation practice to allopathic and osteopathic physicians. Atlanta has an active integrative medicine market and the board has issued reminders that off-label chelation requires informed consent and a documented clinical rationale. The 2005 Pittsburgh pediatric death prompted national board attention to agent selection and infusion safety.